1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32070872 | Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab. | 2020 May | 3 |